FDA Approves Belimumab for Children With Lupus Nephritis FDA Approves Belimumab for Children With Lupus Nephritis

Children with lupus-related kidney damage can now receive the B-cell reducing therapy that adults with lupus nephritis have been receiving for the past 2 years.FDA Approvals

Source: Medscape Pharmacist Headlines - July 28, 2022 Category: Drugs & Pharmacology Tags: Rheumatology News Alert Source Type: news